Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
Clinical trial NCT00691652 · TERMINATED
Trial details
- NCT number
- NCT00691652
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.